Literature DB >> 28326651

Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation.

Noriko Oza1, Hiroshi Isoda2, Toshiki Ono2, Tatsuya Kanto1.   

Abstract

In Japan, hepatitis B or C virus infection has been a major health issue. For the prevention of liver-related deaths, multifaceted strategies have been taken against hepatitis virus. In fiscal year (FY) 2002, nationwide screening for hepatitis was started as a part of health examinations provided by municipal governments. From FY2007, the hepatitis treatment network has been strengthened by the nationwide establishment of regional government-based hepatitis treatment systems, comprising linked regional core centers, specialized institutions for hepatitis treatment, primary care physicians, and regional governments. Special subsidy program for patients with viral hepatitis was started at FY2008. The range of coverage has been expanding from patients treated with interferon to those on nucleotide analogs or interferon-free therapies, including drug prices and examination expenses. The Basic Act on Hepatitis Measures was established in 2009. The Basic Guidelines for Promotion of Control Measures for hepatitis was issued in 2011, comprising nine principles in order to promote measures for hepatitis B and C. The Hepatitis Information Center was established in 2008. Its mission is to provide up-to-date hepatitis-related information, supporting collaboration between regional core centers, and training medical personnel. The revision of the above-mentioned Basic Guidelines in 2016 set the target as the reduction of patients progressing to cirrhosis and/or liver cancer. Achieving this goal definitely requires active collaboration among the national and local governments, regional core centers, and the Hepatitis Information Center, and participation by medical personnel, patients, and people with awareness.
© 2017 The Authors Hepatology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Hepatology.

Entities:  

Keywords:  Basic Act an Hepatitis Measures; Basic Guidelines on Hepatitis Measures; health policy; hepatitis; hepatitis information center; regional core centers

Year:  2017        PMID: 28326651     DOI: 10.1111/hepr.12897

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  15 in total

Review 1.  Regional Program to Reduce Liver Cancer Associated With Viral Hepatitis B: Comprehensive Approach Corroborating With the Media and Regional Government to Improve Population Screening Rate in Saga Prefecture.

Authors:  Yuichiro Eguchi; Hiroshi Isoda; Hirokazu Takahashi
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

Review 2.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

Review 3.  Efficient and practical dissemination of information on viral hepatitis in Japan: an effort by the Hepatitis Information Center, National Center for Global Health and Medicine.

Authors:  Yuko Kitayama; Masaaki Korenaga; Hiroko Setoyama; Tatsuya Kanto
Journal:  Glob Health Med       Date:  2019-10-31

4.  High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use.

Authors:  Akihiro Tamori; Sawako Uchida-Kobayashi; Ritsuzo Kozuka; Hiroyuki Motoyama; Kanako Yoshida; Naoshi Odagiri; Kohei Kotani; Etsushi Kawamura; Hideki Fujii; Atsushi Hagihara; Masaru Enomoto; Norifumi Kawada
Journal:  JGH Open       Date:  2020-06-23

5.  Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data.

Authors:  Kiyotaka Yamazaki; Dendy Macaulay; Yan Song; Yuri Sanchez Gonzalez
Journal:  Infect Dis Ther       Date:  2019-02-15

6.  Transition in the etiology of liver cirrhosis in Japan: a nationwide survey.

Authors:  Hirayuki Enomoto; Yoshiyuki Ueno; Yoichi Hiasa; Hiroki Nishikawa; Shuhei Hige; Yasuhiro Takikawa; Makiko Taniai; Toru Ishikawa; Kohichiroh Yasui; Akinobu Takaki; Koichi Takaguchi; Akio Ido; Masayuki Kurosaki; Tatsuya Kanto; Shuhei Nishiguchi
Journal:  J Gastroenterol       Date:  2019-11-25       Impact factor: 7.527

7.  Nationwide survey on activities of regional core centers for the management of liver disease in Japan: Cumulative analyses by the Hepatitis Information Center 2009-2017.

Authors:  Hiroko Setoyama; Masaaki Korenaga; Yuko Kitayama; Noriko Oza; Naohiko Masaki; Tatsuya Kanto
Journal:  Hepatol Res       Date:  2019-12-18       Impact factor: 4.288

Review 8.  Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view.

Authors:  Junko Tanaka; Tomoyuki Akita; Ko Ko; Yoshihiko Miura; Masahiro Satake
Journal:  Hepatol Res       Date:  2019-08-22       Impact factor: 4.288

9.  Generation Gap for Screening and Treatment of Hepatitis C Virus in Saga Prefecture, Japan: An Administrative Database Study of 35,625 Subjects.

Authors:  Hiroshi Isoda; Satoshi Oeda; Ayako Takamori; Keiko Sato; Michiaki Okada; Shinji Iwane; Hirokazu Takahashi; Keizo Anzai; Yuichiro Eguchi; Kazuma Fujimoto
Journal:  Intern Med       Date:  2019-09-18       Impact factor: 1.271

10.  Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis.

Authors:  Haruna Yamamoto; Hiroaki Ikesue; Mai Ikemura; Rieko Miura; Kazumi Fujita; Hobyung Chung; Yoshiki Suginoshita; Tetsuro Inokuma; Tohru Hashida
Journal:  J Pharm Health Care Sci       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.